Position in ABBV
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,419,770
+$264,010 QoQ
Shares Held
9,616
-3.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#1,816
of 4,153 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hardy Reed LLC holds $12,890,734 across 10 Drug Manufacturers - General names. ABBV ranks #3 (18.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,509 | $4,208,800 | |
| 2 | JNJ |
Johnson & Johnson
|
13,023 | $3,307,451 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
9,616 | $2,419,770 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,034 | $903,869 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
8,689 | $500,660 | |
| 6 | AZN |
Astrazeneca PLC
|
2,496 | $473,291 | |
| 7 | AMGN |
Amgen Inc
|
1,129 | $408,833 | |
| 8 | NVS |
Novartis AG
|
1,440 | $225,676 |
All Filings in ABBV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,419,770 | 9,616 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $2,155,760 | 9,912 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,373,325 | 10,387 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,375,831 | 10,261 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,827,614 | 9,846 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $2,440,488 | 11,648 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,046,037 | 11,514 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $2,276,944 | 11,530 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,977,111 | 11,527 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||